Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Myeloid Cells Exert Immunosuppressive Activity and Have Prognostic Value In Hodgkin Lymphoma

Alessandra Romano, Nunziatina Parrinello, Calogero Vetro, Piera La Cava, Cesarina Giallongo, Daniele Tibullo, Giovanna Motta, Ugo Consoli, MD, Annalisa Chiarenza, MD, PhD, Giuseppe A Palumbo, Francesco Di Raimondo, MD

Blood (2013) 122 (21): 4238.

https://doi.org/10.1182/blood.V122.21.4238.4238

Published: 2013

Journal Articles

Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity In CML Patients At Diagnosis

Cesarina Giallongo, Nunziatina Parrinello, Daniele Tibullo, Piera La Cava, Alessandra Romano, Annalisa Chiarenza, MD, PhD, Fabio Stagno, MD, Paolo G. Vigneri, MD/PhD, Giuseppe A. Palumbo, Francesco Di Raimondo, MD

Blood (2013) 122 (21): 2711.

https://doi.org/10.1182/blood.V122.21.2711.2711

Published: 2013

Journal Articles

Neutrophils Of Multiple Myeloma Are Dysfunctional and Immunosuppressive

Nunziatina Parrinello, Alessandra Romano, Concetta Conticello, Maide Cavalli, Alessia La Fauci, MD, Giuseppina Rizzo, Piera La Cava, Annalisa Chiarenza, MD, PhD, Daniele Tibullo, Cesarina Giallongo, Giuseppe A Palumbo, Francesco Di Raimondo, MD

Blood (2013) 122 (21): 3138.

https://doi.org/10.1182/blood.V122.21.3138.3138

Published: 2013

Journal Articles

Myeloid-Derived Suppressor Cells Increase in Chronic Myeloid Leukemia and Exert Immune Suppressive Activity.

Cesarina Giallongo, Nunziatina Parrinello, Daniele Tibullo, Piera La Cava, Alessandra Cupri, MD, PhD, Annalisa Chiarenza, MD, PhD, Fabio Stagno, Giuseppe A Palumbo, Francesco Di Raimondo

Blood (2012) 120 (21): 2779.

https://doi.org/10.1182/blood.V120.21.2779.2779

Published: 2012

Journal Articles

Myeloid Impairment Contributes to Immunoparesis in Multiple Myeloma but Not MGUS

Alessandra Romano, MD, PhD, Nunziatina Parrinello, Calogero Vetro, Piera La Cava, Annalisa Chiarenza, MD, PhD, Concetta Conticello, MD, Giuseppe A Palumbo, Francesco Di Raimondo

Blood (2012) 120 (21): 1831.

https://doi.org/10.1182/blood.V120.21.1831.1831

Published: 2012

Journal Articles

Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells

Daniele Tibullo, Cesarina Giallongo, Ignazio Barbagallo, Piera La Cava, Nunziatina Parrinello, Giovanni Li Volti, Sr., Giuseppe A Palumbo, Concetta Conticello, MD, Francesco Di Raimondo

Blood (2012) 120 (21): 5005.

https://doi.org/10.1182/blood.V120.21.5005.5005

Published: 2012

Journal Articles

Proteomic and Genomic Profile of High-Risk MDS After Treatment with 5-Azacytidine,

Alessandra Romano, Vincenza Barresi, Carmela Capizzi, Cesarina Giallongo, Musso Nicolo, Piera La Cava, Calogero Vetro, Daniele Tibullo, Nunziatina Parrinello, Giuseppe A Palumbo, MD, Daniele FILIPPO Condorelli, Lance Liotta, MD, Virginia Espina, PhD, Francesco Di Raimondo, MD

Blood (2011) 118 (21): 3818.

https://doi.org/10.1182/blood.V118.21.3818.3818

Published: 2011

Journal Articles

Serotonin Dysregulation Correlates with Both Bone and Active Disease In Multiple Myeloma

Alessandra Romano, Antonella Chiechi, Calogero Vetro, MD, Nunziatina Parrinello, Amy van Meter, Gregory Orloff, MD, Dipti Patel, Alexander I. Spira, PhD, MD, FACP, Francesco Di Raimondo, Lance Liotta, Virginia Espina

Blood (2010) 116 (21): 1920.

https://doi.org/10.1182/blood.V116.21.1920.1920

Published: 2010

Journal Articles

Mechanisms of Heme Oxygenase 1-Induced Resistance to Imatinib In CML Cells.

Daniele Tibullo, Ignazio Barbagallo, Antonio Branca, Cesarina Giallongo, Piera La Cava, PhD, Nunziatina Parrinello, Giovanni Li Volti, Angelo Vanella, Fabio Stagno, MD, Giuseppe A Palumbo, MD, Francesco Di Raimondo

Blood (2010) 116 (21): 3385.

https://doi.org/10.1182/blood.V116.21.3385.3385

Published: 2010

Journal Articles

Absolute Count of Myeloid Derived Suppressor Cells (MDSC) Is Able to Predict the Response to Early-PET In Hodgkin Lymphoma

Alessandra Romano, MD, Nunziatina Parrinello, Calogero Vetro, MD, Piera La Cava, PhD, Daniela Donnarumma, MD, Concetta Conticello, MD, Ugo Consoli, MD, Paolo Fiumara, MD, Annalisa Chiarenza, MD, Giuseppe A Palumbo, MD, Massimo Ippolito, MD, Francesco Di Raimondo, MD

Blood (2010) 116 (21): 3882.

https://doi.org/10.1182/blood.V116.21.3882.3882

Published: 2010

Journal Articles

Bone Turnover Markers In Gaucher Disease Patients.

Gaetano Giuffrida, Maria Rocca Cingari, Nunziatina Parrinello, Alessandra Romano, Anna Triolo, Magda Franceschino, Francesco Di Raimondo

Blood (2010) 116 (21): 3780.

https://doi.org/10.1182/blood.V116.21.3780.3780

Published: 2010

Journal Articles

Variation of T-Reg and CD 200+ T- Lymphocytes After in Vitro Treatment with Active Drugs against CLL.

Nunziatina Parrinello, Piera La Cava, Daniele Tibullo, Cesarina Giallongo, Annalisa Chiarenza, Alessandra Romano, Maide Cavalli, Anna Triolo, Giuseppe A Palumbo, Francesco Di Raimondo

Blood (2009) 114 (22): 1239.

https://doi.org/10.1182/blood.V114.22.1239.1239

Published: 2009

Journal Articles

Myeloid-Derived Suppressor Cells in Patients with Hodgkin Lymphoma.

Nunziatina Parrinello, Piera La Cava, Daniele Tibullo, Cesarina Giallongo, Orazio Di Bartolo, Paolo Spina, Paolo Fiumara, Luciana Schinocca, Concetta Conticello, Annalisa Chiarenza, Giuseppe A Palumbo, Francesco Di Raimondo

Blood (2009) 114 (22): 3662.

https://doi.org/10.1182/blood.V114.22.3662.3662

Published: 2009

Journal Articles

Lenalidomide IS Able to Restore Immune SYSTEM IN MULTIPLE MYELOMA PATIENTS.

Annalisa Chiarenza, Nunziatina Parrinello, Piera La Cava, Eleonora Spina, Daniele Tibullo, Cesarina Giallongo, Maide Cavalli, Alessandra Romano, Paolo Fiumara, Giuseppe A Palumbo, Francesco Di Raimondo

Blood (2009) 114 (22): 4909.

https://doi.org/10.1182/blood.V114.22.4909.4909

Published: 2009

Journal Articles

Myeloid-Derived Suppressor Cells in Patients with Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance.

Nunziatina Parrinello, Piera La Cava, Daniele Tibullo, Cesarina Giallongo, Orazio Di Bartolo, Eleonora Spina, Maide Cavalli, Luciana Schinocca, Anna Triolo, Alessandra Romano, Annalisa Chiarenza, Giuseppe A Palumbo, Francesco Di Raimondo

Blood (2009) 114 (22): 4890.

https://doi.org/10.1182/blood.V114.22.4890.4890

Published: 2009

Journal Articles

Imatinib Increases Cytotoxicity of Melphalan and Their Combination Allows An Efficient Killing of CML Cells.

Cesarina Giallongo, Piera La Cava, Daniele Tibullo, Nunziatina Parrinello, Provvidenza Guagliardo, Vittorio Del Fabro, Fabio Stagno, Annalisa Chiarenza, Carla Consoli, Paolo Spina, Paolo Vigneri, Giuseppe A Palumbo, Francesco Di Raimondo

Blood (2009) 114 (22): 4254.

https://doi.org/10.1182/blood.V114.22.4254.4254

Published: 2009

NARROW

Myeloid Cells Exert Immunosuppressive Activity and Have Prognostic Value In Hodgkin Lymphoma

Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity In CML Patients At Diagnosis

Neutrophils Of Multiple Myeloma Are Dysfunctional and Immunosuppressive

Myeloid-Derived Suppressor Cells Increase in Chronic Myeloid Leukemia and Exert Immune Suppressive Activity.

Myeloid Impairment Contributes to Immunoparesis in Multiple Myeloma but Not MGUS

Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells

Proteomic and Genomic Profile of High-Risk MDS After Treatment with 5-Azacytidine,

Serotonin Dysregulation Correlates with Both Bone and Active Disease In Multiple Myeloma

Mechanisms of Heme Oxygenase 1-Induced Resistance to Imatinib In CML Cells.

Absolute Count of Myeloid Derived Suppressor Cells (MDSC) Is Able to Predict the Response to Early-PET In Hodgkin Lymphoma

Bone Turnover Markers In Gaucher Disease Patients.

Variation of T-Reg and CD 200+ T- Lymphocytes After in Vitro Treatment with Active Drugs against CLL.

Myeloid-Derived Suppressor Cells in Patients with Hodgkin Lymphoma.

Lenalidomide IS Able to Restore Immune SYSTEM IN MULTIPLE MYELOMA PATIENTS.

Myeloid-Derived Suppressor Cells in Patients with Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance.

Imatinib Increases Cytotoxicity of Melphalan and Their Combination Allows An Efficient Killing of CML Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only